ArticlePloS one2025
DNA methylation orchestrates secondary metabolite biosynthesis and transport in Papaver somniferum.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Epigenome Editing for Cannabinoid Yield: Targets, Tools, and Priorities inInternational journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPapaver somniferum (opium poppy) is a major source of benzylisoquinoline alkaloids (BIAs), including pharmaceutically important compounds such as morphine and noscapine. While the enzymatic pathways underlying BIA biosynthesis are well-characterized, the epigenetic mechanisms that govern tissue- and genotype-specific alkaloid accumulation remain poorly understood.
resultsThis study presents a comparative DNA methylation analysis of stem and capsule tissues from P. somniferum cultivars with distinct alkaloid profiles. High-alkaloid-yielding cultivars exhibited hypomethylation of genomic regions involved in photosynthesis, carbon metabolism, protein phosphorylation, and intracellular transport, particularly in stem tissues. DNA methylation patterns revealed tissue- and compound-specific epigenetic signatures: morphine-rich cultivars showed enrichment of differentially methylated regions (DMRs) associated with membrane-related functions, whereas noscapine-rich cultivars exhibited DMR enrichment in nuclear regulatory components and ribosome-associated pathways. Genes encoding cytochrome P450 enzymes, F-box proteins, and ABC transporters were differentially expressed and epigenetically modulated, reflecting a multi-layered regulatory network coordinating biosynthesis, transport, and detoxification of alkaloids.
conclusionsOur findings suggest that noscapine biosynthesis is under strict, evolutionarily conserved regulatory control, while morphine production is supported by transcriptional and metabolic enhancements in photosynthesis and carbohydrate metabolism. This study provides the first integrative epigenomic perspective on alkaloid biosynthesis in the opium poppy and highlights DNA methylation as a key determinant of metabolic specialization.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.